TLR4 and colorectal carcinoma: Future work should validate findings in multi-ethnic cohorts with standardized obstruction criteria, interrogate immune dysfunction mechanisms via single-cell RNA sequencing to dissect CD8+ T-cell states [26], and explore TLR4 antagonists to mitigate potential bacterial-driven inflammation in obstructed CRC [27].